ODRONEXTAMAB

UNII:	8R5CM46UIO
Formula:
Preferred Substance Name:	ODRONEXTAMAB

1801338-64-6
ANTI-CD20 X ANTI-CD3 BISPECIFIC MONOCLONAL ANTIBODY REGN1979
ANTI-CD20/CD3 MONOCLONAL ANTIBODY REGN1979
IMMUNOGLOBULIN G4, ANTI-(HUMAN CD20 ANTIGEN) (HUMAN REGN1979 .GAMMA.-CHAIN), DISULFIDE WITH HUMAN REGN1979 .KAPPA.-CHAIN, DIMER WITH IMMUNOGLOBULIN G4, ANTI-(HUMAN CD3 ANTIGEN) (HUMAN REGN1979 .GAMMA.-CHAIN), DISULFIDE WITH HUMAN REGN1979 .KAPPA.-CHAIN
IMMUNOGLOBULIN G4-KAPPA ANTI-(HOMO SAPIENS B-LYMPHOCYTE ANTIGEN CD20), HETERO DIMER WITH IMMUNOGLOBULIN G4-KAPPA ANTI-(HOMO SAPIENS T-CELL SURFACE GLYCOPROTEIN CD3 EPSILON CHAIN) HUMAN MONOCLONAL ANTIBODY .GAMMA.4 HEAVY CHAIN (1-453) (HOMO SAPIENS VH (IGHV3-9*01 (95%) (IGHD)-IGHJ6*01 (95%)) (8.8.20) (1-127) -HOMO SAPIENS IGHG4*01 (HINGE(S10>P(235)), CH2(E3>P(240),F4>V(241),L5>DEL,G6>A(242))) (128-453)) (141-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (HOMO SAPIENS V-KAPPA (IGKV3-15*01 (98%) IGKJ4*01)(6.3.9) (1'-107') -HOMO SAPIENS IGKC*01 (108'-214')), HETERO DIMER WITH .GAMMA.4 HEAVY CHAIN (1''-449'') (HOMO SAPIENS VH (IGHV3-9*01 (98%) (IGHD)-IGHJ6*01 (90%)) (8.8.16) (1''-123'')-HOMO SAPIENS IGHG4*01 (HINGE(S10>P(231'')), CH2(E3>P(236''),F4>V(237''),L5>DEL,G6>A(238''))) (124''-449'')) (137''-214''')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'''-214''') (HOMO SAPIENS V-KAPPA (IGKV3-15*01 (98%) IGKJ4*01)(6.3.9) (1'''-107''') -HOMO SAPIENS IGKC*01 (108'''-214''')), (229''-233:232''-236)-BISDISULFIDE
MAB HUMAN (IGG4) ANTI P11836 (CD20_HUMAN) & ANTI P07766 (CD3E_HUMAN) (REGN1979)
ODRONEXTAMAB [INN]
ODRONEXTAMAB [USAN]
ODRONEXTAMAB [WHO-DD]
REGN1979
REGN-1979

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ODRONEXTAMAB

Synonyms and Mappings

Resources